ACTICOR BIOTECH: Participation of Acticor Biotech to the 15th World Stroke Congress 2023
Presentation of the latest results on glenzocimab in Stroke patientsPARIS--(BUSINESS WIRE)--Regulatory News:ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, announced to...